CONSTELLATION ULTRAVIT PROBE
Report
- Report Number
- 1644019-2021-00289
- Event Type
- Malfunction
- Date Received
- April 28, 2021
- Date of Event
- April 27, 2021
- Report Date
- October 31, 2021
- Product Code
- MLZ
- UDI-DI
- 00380657509492
- PMA / PMN Number
- K093305
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- 003
Narratives
A SAMPLE WAS NOT RECEIVED AT THE MANUFACTURING SITE FOR EVALUATION; THEREFORE, THE CONDITION OF THE PRODUCT COULD NOT BE VERIFIED. THE PRODUCT WAS PROCESSED AND RELEASED ACCORDING TO THE PRODUCT¿S ACCEPTANCE CRITERIA. A SAMPLE WAS NOT RECEIVED AT THE MANUFACTURING SITE AND THE PRODUCT WAS PROCESSED AND RELEASED ACCORDING TO THE PRODUCT¿S ACCEPTABLE CRITERIA, THEREFORE; THE ROOT CAUSE FOR THE CUSTOMER COMPLAINT ISSUE CANNOT BE DETERMINED. THE EXACT ROOT CAUSE FOR THIS COMPLAINT IS UNKNOWN, THEREFORE, SPECIFIC ACTION WITH REGARDS TO THIS COMPLAINT CANNOT BE TAKEN. ALL PROBES ARE 100% VISUALLY INSPECTED AND TESTED FOR ACTUATION, ASPIRATION, AND CUT DURING MANUFACTURING. COMPLAINTS ARE REVIEWED AND MONITORED AT REGULAR INTERVALS FOR ANY SIGNIFICANT ADVERSE TRENDS. NO ADVERSE TRENDS HAVE BEEN OBSERVED ASSOCIATED WITH THE REPORTED PRODUCT AND EVENT. NO ADDITIONAL ACTION IS REQUIRED AT THIS TIME. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
ONE OPENED PROBE WAS RECEIVED WITH A TIP PROTECTOR, IN A BAG. THE SAMPLE WAS VISUALLY INSPECTED AND FOUND TO BE NON-CONFORMING WITH CLEAR FLUID AND FIBER ON THE NEEDLE. THE SAMPLE WAS THEN FUNCTIONALLY TESTED FOR ACTUATION AND CUT. THE SAMPLE WAS FOUND TO BE CONFORMING FOR CUT AND NON-CONFORMING FOR ACTUATION. THE PROBE SAMPLE WAS DISASSEMBLED AND THE COMPONENTS INSPECTED. NO/MINIMAL WEAR WAS OBSERVED ON THE INNER CUTTER WHEN COMPARED TO THE DEGREE OF WEAR BASED ON CONTINUOUS ACTUATION OF THE PROBE VISUAL STANDARD PHOTOS. GOUGE MARKS AND WEAR MARKS WERE OBSERVED AT A COUPLE LOCATIONS ALONG THE INNER CUTTER. THE SAMPLE WAS RETESTED FOR ACTUATION WITH THE PROBE DRIVER AND WAS ABLE TO ACTUATE. THE INITIAL ACTUATION TEST FAILED DUE TO AN INTERFERENCE WITHIN THE PROBE AND ONCE THE INTERFERENCE (NEEDLE ASSEMBLY) WAS REMOVED THE PROBE WAS ABLE TO ACTUATE. THE NEEDLE HOLDER / RETAINER ASSEMBLY WAS THEN DISASSEMBLED AND COMPONENTS INSPECTED. THE COMPONENTS WERE FOUND TO BE CONFORMING. THE COMPLAINT EVALUATION DOES NOT CONFIRMS THAT THE PROBE SAMPLE HAD A CUT FAILURE, HOWEVER, THE EVALUATION INDICATED THAT THE SAMPLE HAD AN ACTUATION FAILURE. THE CUT FUNCTIONALITY OF THE PROBE WAS CONFORMING, HOWEVER, THE OBSERVED ACTUATION FAILURE COULD HAVE CAUSED THE PROBE TO NOT CUT AT THE TIME THE REPORTED EVENT WAS OBSERVED. THE EXACT CAUSE OF THE ACTUATION FAILURE CANNOT BE DETERMINED FROM THE EVALUATION PERFORMED. THE REPORTED CUT FAILURE WAS NOT CONFIRMED AND THE ROOT CAUSE OF THE ACTUATION FAILURE COULD NOT BE DETERMINED, THEREFORE, NO SPECIFIC ACTION WITH REGARD TO THIS COMPLAINT WAS TAKEN BY THE MANUFACTURING SITE. ALL PROBES ARE 100% VISUALLY INSPECTED AND TESTED FOR ACTUATION, ASPIRATION, AND CUT DURING MANUFACTURING. COMPLAINTS WILL BE CONTINUED TO BE REVIEWED AND MONITORED AT REGULAR INTERVALS FOR ANY SIGNIFICANT ADVERSE TRENDS. NO ADVERSE TRENDS HAVE BEEN OBSERVED ASSOCIATED WITH THE REPORTED PRODUCT AND EVENT. NO FURTHER ACTIONS ARE REQUIRED. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
A CUSTOMER REPORTED THAT THE PROBE DID NOT CUT. THE CONDITION OF ASPIRATION IS UNKNOWN. THE PRODUCT WAS REPLACED AND THE PROCEDURE WAS COMPLETED. THERE WAS NO PATIENT HARM.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 633272 | CONSTELLATION ULTRAVIT PROBE | VITRECTOMY, INSTRUMENT CUTTER | MLZ | NA | 2401113H | 00380657509492 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |